Sprott Capital Partners Team

Alan Ridgeway

Partner

Alan Ridgeway has worked as a publishing research analyst for more than 10 years. Prior to joining Sprott Capital Partners, he covered the Canadian healthcare sector at Scotiabank where he was ranked #1 by Greenwich Associates and #2 by Brendan Wood International. Before working in the capital markets, Mr. Ridgeway held a postdoctoral fellowship at Harvard Medical School where he performed cancer research. Mr. Ridgeway holds a Ph.D. in Biochemistry from Western University, an MBA from Queen’s University and is a CFA® Charterholder.

Important Message

You are now leaving Sprott.com and entering a linked website. Sprott has partnered with ALPS in offering Sprott ETFs. For fact sheets, marketing materials, prospectuses, performance, expense information and other details about the ETFs, you will be directed to the ALPS/Sprott website at SprottETFs.com.

Continue to Sprott Exchange Traded Funds

Important Message

You are now leaving Sprott.com and entering a linked website. Sprott Asset Management is a sub-advisor for several mutual funds on behalf of Ninepoint Partners. For details on these funds, you will be directed to the Ninepoint Partners website at ninepoint.com.

Continue to Ninepoint Partners

Important Message

You are now leaving sprott.com and linking to a third-party website. Sprott assumes no liability for the content of this linked site and the material it presents, including without limitation, the accuracy, subject matter, quality or timeliness of the content. The fact that this link has been provided does not constitute an endorsement, authorization, sponsorship by or affiliation with Sprott with respect to the linked site or the material.

Continue